The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NEO-CESQ study: Neoadjuvant plus adjuvant treatment with cemiplimab in surgically resectable, high risk stage III/IV (M0) cutaneous squamous cell carcinoma.
 
Paolo Antonio Ascierto
Consulting or Advisory Role - 4SC; AstraZeneca; Bayer; Bio-AI Health; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Idera; Immunocore; Italfarmaco; ITeos Therapeutics; Lunaphore Technologies; Medicenna; Merck Serono; Merck Sharp & Dohme; Nektar; Nouscom; Novartis; OncoSec; Pfizer; Pierre Fabre; Regeneron; Replimune; Roche/Genentech; Sandoz; Sanofi; Seagen; Sun Pharma; Ultimovacs; ValoTx
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bio-AI Health; Pfizer; Replimune
 
Paolo Bossi
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD Oncology; Regeneron
Consulting or Advisory Role - Angelini Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD Oncology; Sanofi/Regeneron; Sun Pharma
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD Oncology (Inst); Regeneron (Inst); Roche (Inst)
 
Mario Mandalà
Honoraria - Bristol-Myers Squibb/Sanofi; MSD Oncology; Novartis; Pierre Fabre; Sanofi/Aventis
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre
Research Funding - Novartis (Inst)
 
Paola Queirolo
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pierre Fabre; Roche/Genentech; Sanofi; Sun Pharma Advanced Research Company
Travel, Accommodations, Expenses - MSD Oncology; Sanofi/Regeneron
 
Francesco Spagnolo
No Relationships to Disclose
 
Franco Bassetto
No Relationships to Disclose
 
Vittorio Rampinelli
No Relationships to Disclose
 
Francesco Giovacchini
No Relationships to Disclose
 
Elisabetta Pennacchioli
No Relationships to Disclose
 
Corrado Caraco
No Relationships to Disclose
 
Gianpiero Parrinello
No Relationships to Disclose
 
Domenico Mallardo
No Relationships to Disclose
 
Diana Giannarelli
No Relationships to Disclose
 
Claudia Trojaniello
No Relationships to Disclose
 
Daniela Massi
Honoraria - Bayer HealthCare Pharmacuticals; DiaTech Oncology; MSD; Novartis; Pierre Fabre; Roche; Sanofi; Skyline Diagnostics; Sun Pharma
 
Vanna Chiarion-Sileni
Consulting or Advisory Role - Merck Sharpe & Dohme; Pierre Fabre
Travel, Accommodations, Expenses - Pierre Fabre